Nayzilam

Digital Pharmacist

The RxWiki Digital Pharmacist stamp of approval lets you know that this content has been created and reviewed by a licensed pharmacist.

Nayzilam is used for the short-term treatment of seizure clusters. Do not drink alcohol or take opioid medicines or other medicines that make you sleepy or dizzy while taking Nayzilam.

Nayzilam Overview

Reviewed: July 24, 2019
Updated: 

Nayzilam is a prescription medicine used for the short-term treatment of seizure clusters (also known as “acute repetitive seizures”) in patients 12 years of age and older.

Nayzilam belongs to a group of drugs called benzodiazepines which help to slow down activity in the central nervous system.

This medication comes as a single-dose nasal spray liquid. It is given as one spray (5 mg dose) into one nostril. One additional spray into the opposite nostril may be administered if the seizure cluster is continuing 10 minutes after the first dose.

Common side effects include sleepiness, headache, runny nose, nasal discomfort and throat irritation. Do not drive, operate machinery, or do other activities that require mental alertness until you know how Nayzilam affects you.

How was your experience with ?

First, a little about yourself

Tell us about yourself in a few words?

What tips would you provide a friend before taking ?

What are you taking for?

Choose one
  • Other
  • Anxiety Disorders
  • Psychomotor Agitation
  • Status Epilepticus

How long have you been taking it?

Choose one
  • Less than a week
  • A couple weeks
  • A month or so
  • A few months
  • A year or so
  • Two years or more

How well did work for you?

Did you experience many side effects while taking this drug?

How likely would you be to recommend to a friend?

Nayzilam Drug Class

Back to Top

Nayzilam is part of the drug class:

Nayzilam FDA Warning

Back to Top

WARNING: RISKS FROM CONCOMITANT USE WITH OPIOIDS

Concomitant use of benzodiazepines and opioids may result in profound sedation, respiratory depression, coma, and death.

  • Reserve concomitant prescribing of these drugs for use in patients for whom alternative treatment options are inadequate.

  • Limit dosages and durations to the minimum required.

  • Follow patients for signs and symptoms of respiratory depression and sedation.